GSK Serevent Safety Label Change Coming Soon; Will Advair Be Affected?

GlaxoSmithKline will meet with FDA to discuss the interim results from the company's halted Serevent safety study and determine whether the information should be added to product labeling

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet